| 000 | 01588 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516015142.0 | ||
| 264 | 0 | _c20120106 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1095-8584 | ||
| 024 | 7 |
_a10.1016/j.yjmcc.2010.11.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheng, Hui | |
| 245 | 0 | 0 |
_aTargeting GSK-3 family members in the heart: a very sharp double-edged sword. _h[electronic resource] |
| 260 |
_bJournal of molecular and cellular cardiology _cOct 2011 |
||
| 300 |
_a607-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiomegaly _xdrug therapy |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 |
_aEmbryonic Stem Cells _xphysiology |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aMyocardial Infarction _xpathology |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aTranslational Research, Biomedical |
| 650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
| 700 | 1 | _aWoodgett, James | |
| 700 | 1 | _aMaamari, Mia | |
| 700 | 1 | _aForce, Thomas | |
| 773 | 0 |
_tJournal of molecular and cellular cardiology _gvol. 51 _gno. 4 _gp. 607-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yjmcc.2010.11.020 _zAvailable from publisher's website |
| 999 |
_c20452163 _d20452163 |
||